SCHEMBL1131978

SCHEMBL1131978

CCOC(=O)C(O)=CC(=O)c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.62
ALDH1A1 P00352 2/20 0.58
MAOB P27338 3/20 0.56
NR4A1 P22736 1/20 0.55
NR4A2 P43354 1/20 0.55
NR4A3 Q92570 1/20 0.55
LMNA P02545 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
LTB4R Q15722 1/20 0.53
LTB4R2 Q9NPC1 1/20 0.53
PARP10 Q53GL7 1/20 0.52
ABCG2 Q9UNQ0 1/20 0.52
SRD5A2 P31213 1/20 0.51
PPARG P37231 3/20 0.51
HDAC3 O15379 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC2 Q92769 1/20 0.50
NCOR2 Q9Y618 1/20 0.50
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1131974 1.00 NR1H4 (0.62) NR1H4ALDH1A1MAOBNR4A1NR4A2
SCHEMBL934159 0.90 SMN1; SMN2 (0.59) NR1H4ALDH1A1MAOBPPARGMAPT
SCHEMBL934158 0.90 SMN1; SMN2 (0.59) NR1H4ALDH1A1MAOBPPARGMAPT
SCHEMBL6031200 0.87 MAOB (0.58) MAOBNR4A1NR4A2NR4A3L3MBTL1
SCHEMBL6469830 0.87 MAOB (0.58) MAOBNR4A1NR4A2NR4A3L3MBTL1
SCHEMBL934271 0.86 MAOB (0.54) ALDH1A1MAOBPARP10ABCG2GAA
SCHEMBL934270 0.86 MAOB (0.54) ALDH1A1MAOBPARP10ABCG2GAA
SCHEMBL2089906 0.84 NR1H4 (0.44) NR1H4ALDH1A1MAOBNR4A2LTB4R
SCHEMBL2089903 0.84 NR1H4 (0.44) NR1H4ALDH1A1MAOBNR4A2LTB4R
SCHEMBL3888888 0.84 NR4A1 (0.64) ALDH1A1MAOBNR4A1NR4A2NR4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663105-B1 CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2011-02-16 EP disclosed